Detalhe da pesquisa
1.
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes.
Eur J Clin Invest
; 54(3): e14121, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37929812
2.
Liver fibrosis is associated with an increased risk of non-fatal myocardial infarction.
Eur J Clin Invest
; 53(11): e14061, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435879
3.
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.
Cardiovasc Diabetol
; 18(1): 20, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819210
4.
Myocardial mechano-energetic efficiency is not impaired in patients with metabolically healthy overweight and obesity.
Obesity (Silver Spring)
; 32(5): 888-899, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467153
5.
ß-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.
Diabetes
; 68(6): 1121-1129, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31109941
6.
Metabolic consequences of the occlusion of the main pancreatic duct with acrylic glue after pancreaticoduodenectomy.
Am J Surg
; 210(4): 783-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26004536